Darya Abdulsatar

Darya Abdulsatar

Auto-generated profile, based on publicly available information

Darya Abdulsatar

Department of Medical Laboratory, College of Health Science Techniques, Cihan University,Duhok, Iraq

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in Bioorganic and Medicinal Chemistry Reports
Verified
Journal Article
Closed access
RERonak Haj Ersan
Ronak Haj Ersan
KJKajeen Jasim
Kajeen Jasim
HSHaytham Sabeeh
Haytham Sabeeh
KAKnar Ahmed
Knar Ahmed
DADarya Abdulsatar
Darya Abdulsatar
SAShana Ali
Shana Ali
Compounds bearing naphthalene and benzimidazole pharmacophores have been reported to possess excellent anticancer activity. In view of this, we designed, synthesized and characterized a series of naphthalene substituted benzimidazole derivatives (11–19), and further evaluated them for antiproliferative activities by employing MTT method. Among the nine investigated molecules, compounds (11 and 13) showed good antiproliferation of the tested cancer cell lines with IC50 values ranging from 0.078 to 0.625 µM. In addition, compound (18) exhibited selective cytotoxicity against HepG2 cell lines with high safety to normal cell (HEK293). Furthermore, cytotoxicity studies of these compounds against normal Human embryonic kidney cells (HEK293) revealed that the target molecules were less selective against HEK293 as compared to methotrexate (positive control). The high potency and selective cytotoxicity suggested that compound 18 could be a starting point for further optimization to develop novel antitumor agents towards liver cancer.